Eye movement as a biomarker of schizophrenia: Using an integrated eye movement score

Studies have shown that eye movement abnormalities are possible neurophysiological biomarkers for schizophrenia. The aim of this study was to investigate the utility of eye movement abnormalities in identifying patients with schizophrenia from healthy controls.

[1]  G. Pearlson,et al.  Pursuit eye movements as an intermediate phenotype across psychotic disorders: Evidence from the B-SNIP study , 2015, Schizophrenia Research.

[2]  T. Inada,et al.  Psychotropic dose equivalence in Japan , 2015, Psychiatry and clinical neurosciences.

[3]  Masao Iwase,et al.  An integrated eye movement score as a neurophysiological marker of schizophrenia , 2014, Schizophrenia Research.

[4]  C. Sumiyoshi,et al.  Performance on the Wechsler Adult Intelligence Scale‐III in Japanese patients with schizophrenia , 2014, Psychiatry and clinical neurosciences.

[5]  H. Kazui,et al.  Relation between remission status and attention in patients with schizophrenia , 2014, Psychiatry and clinical neurosciences.

[6]  Alan D. Lopez,et al.  Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[7]  P. Benson,et al.  Simple Viewing Tests Can Detect Eye Movement Abnormalities That Distinguish Schizophrenia Cases from Controls with Exceptional Accuracy , 2012, Biological Psychiatry.

[8]  R. Perlis,et al.  Translating biomarkers to clinical practice , 2011, Molecular Psychiatry.

[9]  J. Sweeney,et al.  Pharmacological treatment effects on eye movement control , 2008, Brain and Cognition.

[10]  J. Sweeney,et al.  Effects of second-generation antipsychotic medication on smooth pursuit performance in antipsychotic-naive schizophrenia. , 2008, Archives of general psychiatry.

[11]  J. Gold,et al.  Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. , 2007, Archives of general psychiatry.

[12]  K. Kasai,et al.  Estimation of premorbid IQ in individuals with Alzheimer’s disease using Japanese ideographic script (Kanji) compound words: Japanese version of National Adult Reading Test , 2006, Psychiatry and clinical neurosciences.

[13]  Ignace T C Hooge,et al.  A quantitative measure for the uniformity of fixation density: The Voronoi method , 2006, Behavior research methods.

[14]  Burkhart Fischer,et al.  Lifespan development of pro- and anti-saccades: multiple regression models for point estimates. , 2005, Brain research. Developmental brain research.

[15]  H. Gibbins,et al.  Short and long term effects of antipsychotic medication on smooth pursuit eye tracking in schizophrenia , 2001, Psychopharmacology.

[16]  M. Thase,et al.  Pursuit tracking impairments in schizophrenia and mood disorders: step-ramp studies with unmedicated patients , 1999, Biological Psychiatry.

[17]  W. Heide,et al.  Distinguishing schizophrenic patients from healthy controls by quantitative measurement of eye movement parameters , 1998, Biological Psychiatry.

[18]  R Freedman,et al.  Age Diminishes Performance on an Antisaccade Eye Movement Task , 1997, Neurobiology of Aging.

[19]  Brown Ea.  Overlooking the obvious. , 1969 .

[20]  D. Levy,et al.  Eye tracking dysfunction in schizophrenia: characterization and pathophysiology. , 2010, Current topics in behavioral neurosciences.

[21]  J. Lindenmayer,et al.  A new five factor model of schizophrenia , 2006, Psychiatric Quarterly.

[22]  D H Brainard,et al.  The Psychophysics Toolbox. , 1997, Spatial vision.

[23]  Y Shimazono,et al.  Exploratory eye movements and neuropsychological tests in schizophrenic patients. , 1992, Schizophrenia bulletin.

[24]  E. A. Brown.  Overlooking the obvious. , 1969, Review of allergy.